Previous preclinical and clinical studies have shown promising results, suggesting that MMP-9 and MMP-2 may predict ischemic stroke outcomes, including hemorrhagic transformation (HT) and cerebral infarction volume [34, 35]. Here, MMP9 is linked to hematocrit.